Iol Chemicals and Pharmaceuticals Ltd.

Pharmaceuticals

FV – Rs 10; 52wks H/L – 833.40/147.35; TTQ – 2.5 Lacs; CMP – Rs 737.65 (As On July 24, 2020);                   

      Market Cap – Rs 4300.91 Crs

Consolidated Financials and Valuations (Amt in Rs Crs unless specified)

About the Company:

IOLCP is India’s one of the leading generic pharmaceutical company, and is a significant player in the Organic chemicals space. IOLCP has a wide presence across various therapeutic categories like, Pain Management, Anti-diabetic, Anti hypertensive, AntiConvulsants, etc.

The company deals in APIs(Active Pharmaceutical Ingredients) and Speciality Chemicals 

It has an API capacity of 12000 TPA which is roughly 34.2% of India’s total API capacity.

API:

In the API division the company presently has a commercial distribution in 6 products: 

1. Ibuprofen (nonsteroidal anti-inflammatory drug -NSAID)
2. Metformin Hydrochloride (mainly used to control high blood sugar)
3. Lamotrigine ( used to treat epilepsy and bipolar disorder)
4. Fenofibrate ( used to reduce the amounts of cholesterol and triglycerides in the blood) 
5. Clopidogrel Bi sulphate ( Stimulates platelets aggression)
6. Ursodeoxycholic acid ( used to reduce the amounts of cholesterol)

They have 10 more products in the advance stage of development 

Speciality Chemicals:

1. Ethyl Acetate (Paints, Varnishes, Cleaning Mixtures)
2. Iso Butyl Benzene ( manufacture of Ibuprofen)
3. Acetyl Chloride ( used in organic synthesis and dyes)
4. Mono Chloro Acetic Acid ( used to make plastics, pharmaceuticals, flavors, cosmetics)

Board of Directors:

1. Rajender Mohan Malla (Chairman and Independent Director)
2. Varinder Gupta (Managing Director)
3. Vijay Garg (Joint Managing Director)

Shareholding Pattern:

Price History:

Peer Comparison:

(All Figures in Rs Cr. unless specified)